AlphaCrest Capital Management’s Select Medical SEM Stock Holding History

AlphaCrest Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-138,391	Closed	-$1.65M	–	951
2022 Q3	$1.65M	Buy	+138,391	New	+$1.97M	0.1%	303
2022 Q1	–	Sell	-64,542	Closed	-$1.02M	–	1391
2021 Q4	$1.02M	Sell	64,542 -28,427	-31%	-$485K	0.04%	780
2021 Q3	$1.81M	Sell	92,969 -21,086	-18%	-$419K	0.09%	354
2021 Q2	$2.6M	Buy	114,055 +90,538	+385%	+$1.88M	0.11%	270
2021 Q1	$432K	Buy	+23,517	New	+$386K	0.02%	867
2020 Q4	–	Sell	-41,957	Closed	-$471K	–	1254
2020 Q3	$471K	Buy	41,957 +7,292	+21%	+$71.8K	0.05%	623
2020 Q2	$275K	Buy	+34,665	New	+$287K	0.05%	671
2020 Q1	–	Sell	-35,902	Closed	-$451K	–	1248
2019 Q4	$451K	Buy	35,902 +3,608	+11%	+$38.9K	0.04%	852
2019 Q3	$288K	Buy	+32,294	New	+$282K	0.02%	1107
2019 Q2	–	Sell	-88,160	Closed	-$669K	–	1126
2019 Q1	$669K	Buy	+88,160	New	+$709K	0.1%	343

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AlphaCrest Capital Management's SEM Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Select Medical (SEM) in Q4 2022, closing a stake of 138,391 shares — an estimated $1.65M sold.

AlphaCrest Capital Management first reported a position in SEM in Q1 2019 and held it in 10 quarters. The position peaked at $2.6M in Q2 2021. 211 funds tracked by Wall St. Rank hold SEM as of Q4 2022.

AlphaCrest Capital Management reported no remaining Select Medical position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 138,391 Select Medical shares in Q4 2022, an estimated $1.65M.
AlphaCrest Capital Management first reported a position in Select Medical in Q1 2019 and held it in 10 quarters.
AlphaCrest Capital Management's Select Medical position peaked at $2.6M in Q2 2021.
211 funds tracked by Wall St. Rank held Select Medical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.